CareDx (CDNA) Misses Q2 EPS by 9c, Maintains FY Rev. Guidance

CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.27), $0.09 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $7.13 million versus the consensus estimate of $7.28 million.

CareDx sees FY2015 revenue of $28-30 million, versus the consensus of $29.60 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• APA Corporation releases Q2 2026 preliminary financial data